Título:
|
Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs
|
Autor/a:
|
Espargaró Colomé, Alba; Medina, Aina; Di Pietro, Ornella; Muñoz-Torrero López-Ibarra, Diego; Sabaté Lagunas, Raimon
|
Otros autores:
|
Universitat de Barcelona |
Abstract:
|
More than 46 million people worldwide suffer from Alzheimer's disease. A large number of potential treatments have been proposed; among these, the inhibition of the aggregation of amyloid β-peptide (Aβ), considered one of the main culprits in Alzheimer's disease. Limitations in monitoring the aggregation of Aβ in cells and tissues restrict the screening of anti-amyloid drugs to in vitro studies in most cases. We have developed a simple but powerful method to track Aβ aggregation in vivo in realtime, using bacteria as in vivo amyloid reservoir. We use the specific amyloid dye Thioflavin-S (Th-S) to stain bacterial inclusion bodies (IBs), in this case mainly formed of Aβ in amyloid conformation. Th-S binding to amyloids leads to an increment of fluorescence that can be monitored. The quantification of the Th-S fluorescence along the time allows tracking Aβ aggregation and the effect of potential antiaggregating agents. |
Materia(s):
|
-Malaltia d'Alzheimer -Pèptids -Agregació (Química) -Disseny de medicaments -Alzheimer's disease -Peptides -Aggregation (Chemistry) -Drug design |
Derechos:
|
cc-by-nc-nd (c) Espargaró Colomé, Alba et al., 2016
http://creativecommons.org/licenses/by-nc-nd/3.0/es |
Tipo de documento:
|
Artículo Artículo - Versión publicada |
Editor:
|
Nature Publishing Group
|
Compartir:
|
|